Functionally distinct subsets of CD4+ effector T cells are defined by the expression of key transcription factors, such as T-bet for T helper 1 (TH1) cells, GATA3 for TH2 cells and RORγt for TH17 cells. Subsets of FOXP3+ regulatory T (Treg) cells also express these transcription factors, but it has been unclear whether these subsets have stable differences in function. Rudensky and colleagues show that induced T-bet+ Treg cells in mice form a stable population that specifically inhibits T-bet+ effector T cells.

Credit: cheney/Alamy

the T-bet+ Treg cell population is maintained even under non-permissive conditions

The authors generated mice expressing red fluorescent protein (RFP) and a tamoxifen-inducible Cre recombinase under the control of the Tbx21 locus (which encodes T-bet), as well as a recombination reporter that permanently tags cells that have expressed Cre with yellow fluorescent protein (YFP). Under steady-state conditions, 30–70% of effector Treg cells in lymphoid and non-lymphoid tissues of these mice were RFP+ (and hence T-bet+). At 3 weeks, 3 months and 7 months after tamoxifen administration, the majority of YFP-tagged Treg cells continued to express RFP, which indicates that T-bet+ Treg cells have intrinsic long-term stability. Furthermore, when the mice were infected with the TH2 cell-inducing helminth Nippostrongylus brasiliensis 3 weeks after tamoxifen administration, YFP+ Treg cells did not lose RFP expression, which indicates that the T-bet+ Treg cell population is maintained even under non-permissive conditions.

Next, Rudensky and colleagues looked at the increase in the number of T-bet+ Treg cells in response to a TH1 cell-polarizing infection. When tamoxifen was administered to the reporter mice 3 weeks before challenge with Listeria monocytogenes, the number of RFP+ Treg cells increased markedly whereas the number of YFP+ cells did not. This indicates that T-bet+ Treg cells differentiate from T-bet precursors during infection rather than arising from an expansion of the steady-state T-bet+ Treg cell population. To preferentially tag the infection-induced T-bet+ cells with YFP, tamoxifen was administered at the peak of the primary response to L. monocytogenes. By day 65 after primary infection, 90% of the YFP+ cells continued to express T-bet and had a greater proliferative response to re-infection than did the bulk RFP+ Treg cell population. Thus, a TH1 cell-polarizing environment induces the de novo differentiation of a stable population of T-bet+ Treg cells that have a strong recall response to the inducing conditions.

Ablation of Foxp3 in T-bet+ Treg cells resulted in lymphadenopathy, T cell activation and immune infiltration of the lungs in 8-week-old mice. The majority of effector T cells in these mice were RFP+ (T-bet+) and levels of interferon-γ (IFNγ) and IL-2 production were increased compared with levels in control mice, which indicates that T-bet+ Treg cells might be involved in specific suppression of TH1 cell responses. There was no effect on the TH2 cell response to N. brasiliensis in these mice. Similar results in bone marrow chimaeric mice showed that diphtheria toxin-mediated punctual ablation of T-bet+ Treg cells resulted in TH1 cell-mediated inflammation. By contrast, mice with selective ablation of T-bet Treg cells had suppressed IFNγ production, but unrestrained production of TH2 and TH17 cell cytokines.

Thus, T-bet+ Treg cells are a stable subset with TH1 cell-specific suppressive activity. Further studies are required to determine whether GATA3+ and RORγt+ Treg cell subsets have analogous roles in the suppression of TH2 and TH17 cell responses, respectively.